Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Corvari

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Pharmaceutical Sciences|February 15, 2007
A simple method for the detection of insoluble aggregates in protein formulationsBei Li, Jose Flores, Vincent Corvari
Pharmaceutical Research|May 26, 2018
Considerations for the Use of Polysorbates in BiopharmaceuticalsMichael T Jones, Hanns-Christian Mahler, Sandeep Yadav, et al.
Journal of Pharmaceutical Sciences|April 3, 2015
Subvisible (2-100 μm) Particle Analysis During Biotherapeutic Drug Product Development: Part 1, Considerations and StrategyLinda O Narhi, Vincent Corvari, Dean C Ripple, et al.
Biologicals : Journal of the International Association of Biological Standardization|September 2, 2015
Subvisible (2-100 μm) particle analysis during biotherapeutic drug product development: Part 2, experience with the application of subvisible particle analysisVincent Corvari, Linda O Narhi, Thomas M Spitznagel, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Pharmaceutical Sciences|February 15, 2007
A simple method for the detection of insoluble aggregates in protein formulationsBei Li, Jose Flores, Vincent Corvari
Pharmaceutical Research|May 26, 2018
Considerations for the Use of Polysorbates in BiopharmaceuticalsMichael T Jones, Hanns-Christian Mahler, Sandeep Yadav, et al.
Journal of Pharmaceutical Sciences|April 3, 2015
Subvisible (2-100 μm) Particle Analysis During Biotherapeutic Drug Product Development: Part 1, Considerations and StrategyLinda O Narhi, Vincent Corvari, Dean C Ripple, et al.
Biologicals : Journal of the International Association of Biological Standardization|September 2, 2015
Subvisible (2-100 μm) particle analysis during biotherapeutic drug product development: Part 2, experience with the application of subvisible particle analysisVincent Corvari, Linda O Narhi, Thomas M Spitznagel, et al.
Pageof 1